GB1378134A - Process for the purification of carcinoembryonic antigen - Google Patents

Process for the purification of carcinoembryonic antigen

Info

Publication number
GB1378134A
GB1378134A GB2261173A GB2261173A GB1378134A GB 1378134 A GB1378134 A GB 1378134A GB 2261173 A GB2261173 A GB 2261173A GB 2261173 A GB2261173 A GB 2261173A GB 1378134 A GB1378134 A GB 1378134A
Authority
GB
United Kingdom
Prior art keywords
particle size
microgranular
meg
cellulose
capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2261173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US252700A external-priority patent/US3867363A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1378134A publication Critical patent/GB1378134A/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/04—Mixed-bed processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB2261173A 1972-05-12 1973-05-11 Process for the purification of carcinoembryonic antigen Expired GB1378134A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US252700A US3867363A (en) 1970-06-01 1972-05-12 Carcinoembryonic antigens

Publications (1)

Publication Number Publication Date
GB1378134A true GB1378134A (en) 1974-12-18

Family

ID=22957148

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2261173A Expired GB1378134A (en) 1972-05-12 1973-05-11 Process for the purification of carcinoembryonic antigen

Country Status (15)

Country Link
JP (1) JPS5912990B2 (enrdf_load_html_response)
AU (1) AU468779B2 (enrdf_load_html_response)
BE (1) BE799405A (enrdf_load_html_response)
CA (1) CA948991A (enrdf_load_html_response)
CH (1) CH583036A5 (enrdf_load_html_response)
DD (1) DD107293A5 (enrdf_load_html_response)
DE (1) DE2323955A1 (enrdf_load_html_response)
DK (1) DK133559B (enrdf_load_html_response)
FR (1) FR2184753B1 (enrdf_load_html_response)
GB (1) GB1378134A (enrdf_load_html_response)
IL (1) IL42119A (enrdf_load_html_response)
IT (1) IT998101B (enrdf_load_html_response)
NL (1) NL7306346A (enrdf_load_html_response)
SE (1) SE403912B (enrdf_load_html_response)
ZA (1) ZA732770B (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
GB2122641B (en) * 1982-06-07 1986-08-06 Otto A Gansow Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
JPS6076395A (ja) * 1983-10-03 1985-04-30 Dainippon Screen Mfg Co Ltd 印刷版の溶出装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens

Also Published As

Publication number Publication date
JPS5912990B2 (ja) 1984-03-27
NL7306346A (enrdf_load_html_response) 1973-11-14
IT998101B (it) 1976-01-20
BE799405A (fr) 1973-11-12
AU5498973A (en) 1974-10-31
AU468779B2 (en) 1976-01-22
CA948991A (en) 1974-06-11
ZA732770B (en) 1974-04-24
SE403912B (sv) 1978-09-11
FR2184753A1 (enrdf_load_html_response) 1973-12-28
FR2184753B1 (enrdf_load_html_response) 1977-11-04
IL42119A (en) 1976-08-31
CH583036A5 (enrdf_load_html_response) 1976-12-31
DD107293A5 (enrdf_load_html_response) 1974-07-20
DE2323955A1 (de) 1973-11-22
DK133559C (enrdf_load_html_response) 1977-02-21
IL42119A0 (en) 1973-06-29
DK133559B (da) 1976-06-08
JPS4947521A (enrdf_load_html_response) 1974-05-08

Similar Documents

Publication Publication Date Title
GB1356911A (en) Purification and fractionation of carcinoembryonic antigen
US4343736A (en) Process for recovering interferon
US3002823A (en) Process of separating materials having different molecular weights and dimensions
Allen et al. Isolation of Vitamin B12-binding Proteins Using Affinity Chromatography: I. PREPARATION AND PROPERTIES OF VITAMIN B12-SEPHAROSE
Kolb et al. Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin
Flodin et al. Separation of acidic oligosaccharides by gel filtration
TW283710B (enrdf_load_html_response)
Remy et al. Purification of yeast phenylalanyl-tRNA synthetase by affinity chromatography, on a tRNAPhe-sepharose column
GB1321997A (en) Carcinoembryonic antigen
US4440675A (en) Human immune interferon
GB8824869D0 (en) Synthetic antibody
US3897309A (en) Process for removing pyrogenic material from aqueous solutions
GB1378134A (en) Process for the purification of carcinoembryonic antigen
Cifonelli et al. The purification of hyaluronic acid by the use of charcoal
Smith et al. Production of mitogenic factor by concanavalin A stimulated lymphocytes
Sølling et al. A rapid method for the purification of glycogen synthetase I and D utilising Concanavalin A bound to agarose
US4658017A (en) Method for the large scale purification of human fibroblast interferon
US3651231A (en) Process for preparing lactogenic factor
Phillips et al. Gel-filtration of the α-Toxin of Clostridium oedematiens Type B
FUNATSU et al. Structure and Toxic Function of Ricin I Purification Procedures of Ricin D
GB1295376A (enrdf_load_html_response)
Dean et al. Separation of a proteoglycan fraction from Kurloff cells stimulating protein synthesis in macrophages
Blandamer et al. Dextran-gel Filtration in the Purification of a Crustacean α-Amylase
Schmincke et al. A simplified procedure for large scale preparation of purified animal DNA-dependent RNA polymerase
GB1494230A (en) Process for the purification of alkali metal or ammonium insulin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee